We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

86 hedge funds and large institutions have $61.6M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $4.23M | Put options by funds: $1.76M

82% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 17

58% more capital invested

Capital invested by funds: $39M → $61.6M (+$22.6M)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

1% less funds holding

Funds holding: 87 → 86 (-1)

Holders
86
Holders Change
-1
Holders Change %
-1.15%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
17
Closed
19
Calls
$4.23M
Puts
$1.76M
Net Calls
+$2.47M
Net Calls Change
+$1.25M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$1.52M
2
Millennium Management
Millennium Management
New York
+$1.45M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.31M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.01M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$966K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.19M
2
SSA
Schonfeld Strategic Advisors
New York
-$1.12M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.1M
4
Group One Trading
Group One Trading
Illinois
-$1.02M
5
Simplex Trading
Simplex Trading
Illinois
-$814K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
$4.18K – – –
AF
77
Allworth Financial
California
$3.24K – – –
CFGS
78
Concourse Financial Group Securities
Alabama
$2.23K – – –
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$1.33K – – –
UBS Group
80
UBS Group
Switzerland
$1.33K -$10K -2,872 -90%
Lazard Asset Management
81
Lazard Asset Management
New York
$1K +$1.04K +298 New
PCA
82
Providence Capital Advisors
North Carolina
$916 – – –
NA
83
NewEdge Advisors
Louisiana
$864 – – –
Citadel Advisors
84
Citadel Advisors
Florida
$52 -$153K -43,954 -100%
Macquarie Group
85
Macquarie Group
Australia
$6 +$4.66K +1,338 New
Marshall Wace
86
Marshall Wace
United Kingdom
– -$1.1M -360,293 Closed
Simplex Trading
87
Simplex Trading
Illinois
– -$814K -233,626 Closed
Adage Capital Partners
88
Adage Capital Partners
Massachusetts
– -$458K -150,000 Closed
CWM
89
Curi Wealth Management
North Carolina
– -$216K -70,795 Closed
6CM
90
683 Capital Management
New York
– -$194K -63,765 Closed
VF
91
Virtu Financial
New York
– -$136K -44,726 Closed
EGM
92
Engineers Gate Manager
New York
– -$136K -44,639 Closed
AG
93
Algert Global
California
– -$117K -38,470 Closed
JF
94
Jump Financial
Illinois
– -$105K -34,400 Closed
BFM
95
Boothbay Fund Management
New York
– -$61.6K -20,195 Closed
Bank of New York Mellon
96
Bank of New York Mellon
New York
– -$53.7K -17,607 Closed
TSS
97
Two Sigma Securities
New York
– -$42.6K -13,976 Closed
Financial Engines Advisors
98
Financial Engines Advisors
California
– -$37.6K -12,333 Closed
AIMA
99
Ables Iannone Moore & Associates
Georgia
– -$14.4K -4,732 Closed
S
100
SignatureFD
Georgia
– -$2.78K -910 Closed
1 2 3
4
5

GTHX Hedge Fund Activity: Q1 2024 in Review

86 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2024, worth a combined $61.6M — up 58% from $39M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of GTHX and 18 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 31 added.

The largest buyer was Goldman Sachs, adding an estimated $1.52M. The largest seller was Susquehanna International Group, cutting an estimated $2.19M.

  • 86 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2024, down from 87 in Q4 2023.
  • Funds reported $61.6M of G1 Therapeutics, Inc. Common Stock stock for Q1 2024, up 58% quarter-over-quarter.
  • 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of -1 holder.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2024 was Goldman Sachs, an estimated $1.52M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2024 was Susquehanna International Group, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2024.